Children'S Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Chronic myeloid leukaemia1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial

Status

• Completed2 trials

Lead sponsor

• Bristol-Myers Squibb1 trial
• Pharmacyclics LLC.1 trial

Closed trials

• Completed

  Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

  NCT03790332· Phase 1/2· Pharmacyclics LLC.· Source

• Completed

  A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib

  NCT00777036· Phase 2· Bristol-Myers Squibb· Source